
Carbios and Indorama Ventures Reaffirm Partnership to Build First-of-a-kind PET Biorecycling Plant in France
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005872/en/
Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France
Carbios (Euronext Growth Paris: ALCRB), a biotech company developing and industrializing biological solutions to reinvent the life cycle of plastic and textiles, and Indorama Ventures Public Company Limited (IVL) (Bloomberg ticker IVL.TB), a global sustainable chemical producer, announce today the signing of a non-binding Memorandum of Understanding (MOU) to form a Joint Venture for the construction of the world’s first PET biorecycling plant in France1.
Based on and subject to the comprehensive terms set out in the MOU, Indorama Ventures plans to mobilize about €110 million for the Joint Venture in equity and non-convertible loan financing2, pending final engineering documentation and final economic feasibility studies. Both parties have acknowledged their mutual support for the implementation of the project and their intent to finalize contract documentation before end 2023.
Subject to the successful performance of this first plant in France, Indorama Ventures confirms its intention to potentially expand the technology to other PET sites for future developments.
Under the agreement signed today, Carbios, which filed for plant permitting in December 2022, should acquire 13ha land from Indorama Ventures’ existing PET plant at Longlaville and expects to be granted permits by Q3 2023, allowing start of construction by end of 2023 and targeted commissioning in 2025. The land surface offers the possibility to double capacity. Pursuant to this MOU, Indorama Ventures shall ensure 100% of output repolymerization and both partners shall collaborate to secure feedstock supply.
The total capital investment for the new plant is re-estimated to be around €230 million, taking into account recent impact from inflation. Project costs shall be financed by the sums mobilized by Indorama Ventures, the French State and Grand-Est Region subsidies available for the project3, and by equity capitalization of the Joint Venture by Carbios. Part of Carbios’ equity injection into the Joint Venture shall be financed by a portion of Carbios’ current cash position (i.e. €86 million as of 30 April 2023). Carbios is actively examining the best options to finance its remaining equity injection into the Joint Venture and will choose the most appropriate solution and timeline based on market conditions.
The project is part of Indorama Ventures’ Vision 2030 ambition to build on its leadership as a global sustainable chemical company. The company’s ESG commitments include spending $1.5 billion to increase its recycling capacity to 50 billion PET bottles per year by 2025 and 100 billion bottles per year by 2030. To meet these goals, Indorama Ventures, the world’s largest producer of recycled PET resin used in beverage bottles, is investing in new recycling technologies, including advanced recycling, in addition to expanding its global footprint of mechanical recycling sites, including two in France.
Carbios has developed a disruptive enzymatic depolymerization technology that enables efficient and solvent-free recycling of PET plastic and textile waste into virgin-like products with an aim to achieve true circularity. Carbios has ambitious plans to become a leading technology provider in advanced recycling of PET by 2035. After successful ongoing operations in its demonstration plant in Clermont-Ferrand in France, Carbios has been collaborating with Indorama Ventures for over a year to assess the commercial and technical feasibility of the technology. The world’s first industrial-scale enzymatic PET recycling plant at Longlaville will have a capacity to process about 50,000 tons of post-consumer PET waste per year, including waste that is not recyclable mechanically, equivalent to 2 billion PET colored bottles or 2.5 billion PET trays.
Yash Lohia, Chairman of the ESG Council at Indorama Ventures, said:“We are encouraged by the positive results of the due diligence our teams have performed so far on the technical soundness of Carbios’ technology. We are confident that this groundbreaking development could be a valuable addition to the range of solutions for the circular economy of PET plastics and fibers. Subject to the successful performance of the Longlaville Project, we are considering expanding Carbios’ technology at other sites worldwide for future development.”
Emmanuel Ladent, CEO of Carbios, said: “Today’s announcement is a significant landmark in our partnership with Indorama Ventures and a major step forward in realizing our joint first-of-a-kind PET biorecycling plant. The technical due diligence jointly undertaken with Indorama proves the robustness of Carbios’ disruptive technology. At Carbios, we are committed to bringing plastic and textiles into the circular economy. Our first reference unit at Longlaville is a springboard for our industrial and commercial deployment worldwide in order to reach our leadership goals in advanced recycling of PET.”
# # #
About Carbios:
Carbios is a biotech company developing and industrializing biological solutions to reinvent the life cycle of plastic and textiles. Inspired by nature, Carbios develops enzyme-based processes to break down plastic with a mission to avoid plastic and textile pollution, and accelerate the transition to a circular economy. Its two disruptive technologies for the biorecycling of PET and the biodegradation of PLA are reaching industrial and commercial scale. Its biorecycling demonstration plant has been operational since 2021 and a first-of-a-kind reference unit, in partnership with Indorama Ventures, is due to be commissioned in 2025. Carbios has received scientific recognition, notably with the cover of Nature, and is supported by prestigious brands in the cosmetics, Food & Beverage and apparel industries to enhance their products’ recyclability and circularity. Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe are members of a packaging consortium founded by Carbios and L’Oréal, Patagonia, PUMA, PVH Corp. and Salomon collaborate with Carbios in a textile consortium.
Visit www.carbios.com/en to find out more about biotechnology powering plastic and textile circularity.
Twitter: Carbios / LinkedIn: Carbios / Instagram: insidecarbios
Information on Carbios shares:
ISIN Code: FR0011648716
Ticker Code: Euronext Growth: ALCRB
LEI: 969500M2RCIWO4NO5F08
Carbios, founded in 2011 by Truffle Capital, is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.
About Indorama Ventures
Indorama Ventures Public Company Limited, listed in Thailand (Bloomberg ticker IVL.TB), is one of the world’s leading petrochemicals producers, with a global manufacturing footprint across Europe, Africa, Americas, and Asia Pacific. The company’s portfolio comprises Combined PET, Integrated Oxides and Derivatives, and Fibers. Indorama Ventures products serve major FMCG and automotive sectors, i.e., beverages, hygiene, personal care, tire and safety segments. Indorama Ventures has about 26,000 employees worldwide and revenue of US$18.7 billion in 2022. The Company is listed in the Dow Jones Emerging Markets and World Sustainability Indices (DJSI).
Disclaimer on forward-looking statements and risk factors:
Certain information contained in this press release are forward-looking statements, not historical data and should not be construed as a guarantee that the facts and data stated will occur. These forward-looking statements are based on data, assumptions and estimates considered reasonable by Carbios. Carbios operates in a competitive and rapidly evolving environment. It is therefore not in a position to anticipate all risks, uncertainties or other factors that may affect its business, their potential impact on its business or the extent to which the materialization of a risk or combination of risks could lead to results that differ significantly from those mentioned in any forward-looking statement. Carbios draws your attention to the fact that forward-looking statements are in no way a guarantee of its future performance and that its actual financial position, results and cash flows and the development of the sector in which Carbios operates may differ significantly from those proposed or suggested by the forward-looking statements contained in this document. In addition, even if Carbios’s financial position, results, cash flows and developments in the industry in which it operates are consistent with the forward-looking information contained in this document, such results or developments may not be a reliable indication of Carbios’s future results or developments. Readers are advised to carefully consider the risk factors described in the Universal registration document filed with the French Market Authority (“AMF”), as well as in the half-year financial report available free of charge on the Company’s website. Should all or any part of these risk factors materialize or others, in no case whatsoever will Carbios be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages. This information is given only as of the date of this press release. Carbios makes no commitment to publish updates to this information or on the assumptions on which it is based, except in accordance with any legal or regulatory obligation applicable to it.
1 Refer to press release published by Carbios and Indorama Ventures on 23 February 2022
2 Both equity and non-convertible loan financing by Indorama Ventures shall only be made in the Joint Venture and not in Carbios
3 Refer to press release published by Carbios on 31 May 2023
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230601005872/en/
Contact information
Contacts: Carbios
Carbios
Press Relations
Melissa Flauraud
melissa.flauraud@carbios.com
+33 (0)6 30 26 50 04
Investor Relations
Benjamin Audebert
contact@carbios.com
+33 (0)4 73 86 51 76
Press Relations (France)
Iconic
Marie-Virginie Klein
mvk@iconic-conseil.com
+33 (0)1 44 14 99 96
Press Relations (US)
Rooney Partners
Kate L. Barrette
kbarrette@rooneyco.com
+1 212 223 0561
Press Relations (DACH & UK)
MC Services
Anne Hennecke
carbios@mc-services.eu
+49 (0)211 529 252 22
Contacts: Indorama Ventures
Stuart Kelly
Tel: +66 2 661 6661 ext. 508
stuart.k@indorama.net
Thanasak Phakdee
Tel: +662 661 6661 ext. 678
thanasak.p@indorama.net
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KuCoin Breaks 30 Million Users as the Exchange Celebrates Its 6 th Anniversary25.9.2023 12:00:00 CEST | Press release
KuCoin, a top five cryptocurrency exchange in the world, is celebrating its 6th Anniversary with a breakthrough achievement of surpassing 30 million users, two momentous milestones of its journey at the same time. This remarkable achievement is a testament to KuCoin's commitment to excellence and its unwavering dedication to the global crypto community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230925301707/en/ KuCoin, a top five cryptocurrency exchange in the world, is celebrating its 6th Anniversary with a breakthrough achievement of surpassing 30 million users, two momentous milestones of its journey at the same time. To commemorate this celebration, KuCoin is rolling out the campaign "Rising Together: Celebrate 6th Anniversary of KuCoin with Million-Dollar Prize Pool", giving back to the community that has been integral to its success. (Graphic: Business Wire) Since its inception, KuCoin has been committed to provid
Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award25.9.2023 11:42:00 CEST | Press release
In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the Aster Guardians Global Nursing Award. The award invites registered nurses from across the world to apply by submitting nomination of their work on www.asterguardians.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230924862974/en/ Nurses can apply in one Primary and up to two Secondary areas of contribution, namely – Patient Care, Nursing Leadership, Nursing Education, Social or Community service and Research/ Innovation/ Entrepreneurship in Healthcare. The secondary areas of contribution can be optional. All applications received will follow a stringent review process led by an independent jury and an external advisory firm – Ernst & Young LLP (EY). The Grand Jury, consisting of an independent panel of renowned experts will review the shortlisted applicatio
Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals25.9.2023 11:00:00 CEST | Press release
Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply. Dr. Urs Spitz, CEO and President of Biosynth, commented, “We are very excited for Pepceuticals to be joining Biosynth. The Pepceuticals team has great expertise in optimizing the production of peptides and working at GMP and larger scales, making it a natural fit for Biosynth as we round out our peptide offering." Ehab Alramahy, Senior Vice President, Head of Peptide Division, added “The acquisition of Pepceuticals into the Biosynth family strengthens our position in the peptide field. As we've built the peptide division, our goal has always been to offer a seamless, comprehensive service to our customers. The acquisition represents an important step which allows us to extend our support t
Mercedes-Benz Teams up With Mastercard to Introduce Native In-Car Payments at the Pump: Pay by Fingerprint Directly in the Car With Mercedes pay+25.9.2023 09:00:00 CEST | Press release
Mercedes-Benz customers in Germany can now start the fueling process directly from their vehicle and pay digitally by fingerprint. Eliminating the need to enter a PIN or authenticate via mobile device, drivers can now leverage convenient payments to enhance the in-vehicle experience. The native in-car payment service via Mercedes pay+ will turn the car into a form of payment device and can be used to make payments at service stations using the fingerprint sensor integrated into the MBUX infotainment system. This is now live with Mastercard debit and credit cards in current Mercedes-Benz models.1 Fingerprint payment authorization at a gas station represents the first use case for native in-car payments at the point of sale, in addition to Mercedes-Benz as the world's first automaker to integrate Mastercard's Secure Card on File for Commerce platform into the car. This technology allows for transaction data to be encrypted using uniquely assigned cryptograms,2 in turn protecting sensitiv
Capcom’s Monster Hunter Rise: Sunbreak Wins Grand Award and Resident Evil 4 Wins Award for Excellence in the Games of the Year Division at the Japan Game Awards: 2023!25.9.2023 09:00:00 CEST | Press release
Capcom Co., Ltd. (TOKYO:9697) today announced that Monster Hunter Rise: Sunbreak was awarded the Grand Award and Resident Evil 4 was awarded an Award for Excellence in the Games of the Year Division of the Japan Game Awards: 2023 (held by the Computer Entertainment Supplier’s Association), while Dragon’s Dogma 2 won an award in the Future Division. The prizes were announced at Tokyo Game Show 2023, which was held from September 21-24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230925905754/en/ Monster Hunter Rise: Sunbreak is the winner of the Grand Award in the Games of the Year Division at the Japan Game Awards: 2023, and has garnered acclaim for its new locales, monsters, and never-before-experienced hunting actions, while boasting sales of over 6.1 million units worldwide (as of June 30, 2023). (Graphic: Business Wire) Winner of the Grand Award, Monster Hunter Rise: Sunbreak is a massive premium expansion for Monster